Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hims, Amazon and Hers Health
Hims & Hers Health: The Amazon Curse Is Being Overstated
Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make it a compelling buy.
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new service Thursday that offers upfront pricing for telehealth visits for a range of issues and ailments — including men’s hair loss,
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits.
Hold Rating for Hims & Hers Health Amidst Competitive Pressure from Amazon’s Telehealth Services
Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
1d
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...
12h
on MSN
Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 24%
Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...
Fierce Healthcare
6h
Health tech Q3 earnings recap—Hims & Hers, Doximity, Waystar
The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...
Drug Store News
2d
Hims & Hers Health plans to launch generic of Novo Nordisk's Victoza
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Yahoo Finance
4d
Hims & Hers' Shares Jump 17%: Explosive Growth, Insider Confidence, and Big Money Moves
Last week, Hims &
Hers
Health
(NYSE:HIMS) dropped another mic with its latest earnings, and the numbers are mind-blowing.
Benzinga.com
3d
Unpacking the Latest Options Trading Trends in Hims & Hers Health
Investors with a lot of money to spend have taken a bullish stance on Hims &
Hers
Health
HIMS. And retail traders should ...
AOL
2d
What's Going On With Hims & Hers Health Stock On Wednesday?
Health
and wellness platform Hims &
Hers
Health
, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...
Fintel on MSN
19h
B of A Securities Downgrades Hims & Hers Health (HIMS)
Fintel reports that on November 14, 2024, B of A Securities downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback